Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
RWD102 ASSESSING THE COST-UTILITY OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE TREATMENT AND THE NEED FOR REAL-WORLD EVIDENCE: A SINGAPORE PERSPECTIVE
PaperCitations, authors & open-access status
RWD102 ASSESSING THE COST-UTILITY OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE TREATMENT AND THE NEED FOR REAL-WORLD EVIDENCE: A SINGAPORE PERSPECTIVE is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2025 year and hybrid oa status.
0
Citations
2025
Year
hybrid
OA Status